About JAYWING THERAPEUTICS, LLC
Jaywing Therapeutics, LLC is a startup founded in March 2024 with a mission to develop kappa opioid receptor antagonists for treating stress disorders. The company is focused on preclinical research for Nalfuraprant, a medication intended to improve stress resilience and support recovery from substance use and mental health conditions.
Development of kappa opioid receptor antagonistsPreclinical research and drug developmentInvestigational use of Nalfuraprant for stress-related conditions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to JAYWING THERAPEUTICS, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.